Cell and tissue tropism of enterovirus 71 and other enteroviruses infections

Journal of Biomedical Science

Volumn 21, Issue 1, 2014, Pages

  Lin, Jing Yi ^a   Shih, Shin Ru ^b,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HOST FACTOR; INTERFERON; INTERNAL RIBOSOMAL ENTRY SITE TRANSACTIVATING FACTOR; MICRORNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

CELL TROPISM; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; HOST; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE TROPISM; TROPISM; VIRUS CELL INTERACTION; VIRUS STRAIN; VIRUS TRANSCRIPTION; ENTEROVIRUS; EPIDEMIC; GENETICS; HAND FOOT AND MOUTH DISEASE; PATHOGENICITY; VIROLOGY; VIRUS REPLICATION;

ENTEROVIRUS; HUMAN ENTEROVIRUS 71; PICORNAVIRIDAE;

DISEASE OUTBREAKS; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; HAND, FOOT AND MOUTH DISEASE; HUMANS; TROPISM; VIRUS REPLICATION;

EID: 84899489845     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-21-18     Document Type: Review

References (67)

1. Enterovirus 71 infections and neurologic disease-United States, 1977-1991. Alexander JP Jr, Baden L, Pallansch MA, Anderson LJ, J Infect Dis 1994 169 905 908 10.1093/infdis/169.4.905 8133108
2. An epidemic of enterovirus 71 infection in Taiwan. Taiwan enterovirus epidemic working group. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR, N Engl J Med 1999 341 929 935 10.1056/NEJM199909233411301 10498487
3. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, Cardosa MJ, J Virol 2001 75 7732 7738 10.1128/JVI.75.16.7732-7738.2001 11462047
4. An overview of the evolution of enterovirus 71 and its clinical and public health significance. McMinn PC, FEMS Microbiol Rev 2002 26 91 107 10.1111/j.1574-6976.2002.tb00601.x 12007645
5. Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Shimizu H, Utama A, Yoshii K, Yoshida H, Yoneyama T, Sinniah M, Yusof MA, Okuno Y, Okabe N, Shih SR, Chen HY, Wang GR, Kao CL, Chang KS, Miyamura T, Hagiwara A, Jpn J Infect Dis 1999 52 12 15 10808253
6. Enterovirus 71 outbreak in the People's Republic of China in 2008. Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, He Y, Bu G, Zhou S, Wang J, Qi J, J Clin Microbiol 2009 47 2351 2352 10.1128/JCM.00563-09 19439545
7. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Brown BA, Pallansch MA, Virus Res 1995 39 195 205 10.1016/0168-1702(95)00087-9 8837884
8. Far upstream element binding protein 1 binds the internal ribosomal entry site of enterovirus 71 and enhances viral translation and viral growth. Huang PN, Lin JY, Locker N, Kung YA, Hung CT, Lin JY, Huang HI, Li ML, Shih SR, Nucleic Acids Res 2011 39 9633 9648 10.1093/nar/gkr682 21880596
9. Viral and host proteins involved in picornavirus life cycle. Lin JY, Chen TC, Weng KF, Chang SC, Chen LL, Shih SR, J Biomed Sci 2009 16 103 10.1186/1423-0127-16-103 19925687
10. Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5′ untranslated region and participates in virus replication. Lin JY, Li ML, Huang PN, Chien KY, Horng JT, Shih SR, J Gen Virol 2008 89 2540 2549 10.1099/vir.0.2008/003673-0 18796723
11. Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Lin JY, Li ML, Shih SR, Nucleic Acids Res 2009 37 47 59 10.1093/nar/gkn901 19010963
12. hnRNP A1 interacts with the 5′ untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. Lin JY, Shih SR, Pan M, Li C, Lue CF, Stollar V, Li ML, J Virol 2009 83 6106 6114 10.1128/JVI.02476-08 19339352
13. Host factors in enterovirus 71 replication. Shih SR, Stollar V, Li ML, J Virol 2011 85 9658 9666 10.1128/JVI.05063-11 21715481
14. Viral and host factors that contribute to pathogenicity of enterovirus 71. Huang HI, Weng KF, Shih SR, Future Microbiol 2012 7 467 479 10.2217/fmb.12.22 22439724
15. Structure, function and evolution of picornaviruses. Stanway G, J Gen Virol 1990 71 Pt 11 2483 2501 2254747
16. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. Brown BA, Oberste MS, Alexander JP Jr, Kennett ML, Pallansch MA, J Virol 1999 73 9969 9975 10559310
17. The molecular basis of mouse adaptation by human enterovirus 71. Chua BH, Phuektes P, Sanders SA, Nicholls PK, McMinn PC, J Gen Virol 2008 89 1622 1632 10.1099/vir.0.83676-0 18559932
18. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1. Zaini Z, Phuektes P, McMinn P, Virus Res 2012 167 86 96 10.1016/j.virusres.2012.04.009 22575826
19. A single mutation in capsid protein VP1 (Q145E) of a genogroup C4 strain of human enterovirus 71 generates a mouse-virulent phenotype. Zaini Z, McMinn P, J Gen Virol 1935-1940 2012 93
20. Biological significance of a human enterovirus B-specific RNA element in the 3′ nontranslated region. Merkle I, van Ooij MJ, van Kuppeveld FJ, Glaudemans DH, Galama JM, Henke A, Zell R, Melchers WJ, J Virol 2002 76 9900 9909 10.1128/JVI.76.19.9900-9909.2002 12208967
21. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5′ nontranslated region. Dunn JJ, Chapman NM, Tracy S, Romero JR, J Virol 2000 74 4787 4794 10.1128/JVI.74.10.4787-4794. 2000 10775617
22. Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Gromeier M, Alexander L, Wimmer E, Proc Natl Acad Sci U S A 1996 93 2370 2375 10.1073/pnas.93.6.2370 8637880
23. Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3. Guest S, Pilipenko E, Sharma K, Chumakov K, Roos RP, J Virol 2004 78 11097 11107 10.1128/JVI.78.20.11097-11107.2004 15452230
24. Determinants in the 5′ noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. Kawamura N, Kohara M, Abe S, Komatsu T, Tago K, Arita M, Nomoto A, J Virol 1989 63 1302 1309 2536835
25. Mapping of attenuating sequences of an avirulent poliovirus type 2 strain. Moss EG, O'Neill RE, Racaniello VR, J Virol 1884-1890 1989 63
26. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. Westrop GD, Wareham KA, Evans DM, Dunn G, Minor PD, Magrath DI, Taffs F, Marsden S, Skinner MA, Schild GC, Almond JW, J Virol 1989 63 1338 1344 2536836
27. The stem loop II within the 5′ nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model. Dunn JJ, Bradrick SS, Chapman NM, Tracy SM, Romero JR, J Infect Dis 2003 187 1552 1561 10.1086/374877 12721935
28. A single nucleotide in stem loop II of 5′-untranslated region contributes to virulence of enterovirus 71 in mice. Yeh MT, Wang SW, Yu CK, Lin KH, Lei HY, Su IJ, Wang JR, PLoS One 2011 6 27082 10.1371/journal.pone.0027082 22069490
29. Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells. Campbell SA, Lin J, Dobrikova EY, Gromeier M, J Virol 2005 79 6281 6290 10.1128/JVI.79.10.6281-6290.2005 15858012
30. Activity of a type 1 picornavirus internal ribosomal entry site is determined by sequences within the 3′ nontranslated region. Dobrikova E, Florez P, Bradrick S, Gromeier M, Proc Natl Acad Sci U S A 2003 100 15125 15130 10.1073/pnas.2436464100 14645707
31. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. Arita M, Shimizu H, Nagata N, Ami Y, Suzaki Y, Sata T, Iwasaki T, Miyamura T, J Gen Virol 2005 86 1391 1401 10.1099/vir.0.80784-0 15831951
32. An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. Arita M, Nagata N, Iwata N, Ami Y, Suzaki Y, Mizuta K, Iwasaki T, Sata T, Wakita T, Shimizu H, J Virol 2007 81 9386 9395 10.1128/JVI.02856-06 17567701
33. Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. Arita M, Ami Y, Wakita T, Shimizu H, J Virol 2008 82 1787 1797 10.1128/JVI.01798-07 18057246
34. Modification of the untranslated regions of human enterovirus 71 impairs growth in a cell-specific manner. Kok CC, Phuektes P, Bek E, McMinn PC, J Virol 2012 86 542 552 10.1128/JVI.00069-11 22031931
35. Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. Cordey S, Petty TJ, Schibler M, Martinez Y, Gerlach D, van Belle S, Turin L, Zdobnov E, Kaiser L, Tapparel C, PLoS Pathog 2012 8 1002826 10.1371/journal.ppat.1002826 22910880
36. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H, Nat Med 2009 15 794 797 10.1038/nm.1961 19543284
37. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S, Nat Med 2009 15 798 801 10.1038/nm.1992 19543282
38. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Yang B, Chuang H, Yang KD, Virol J 2009 6 141 10.1186/1743-422X-6-141 19751532
39. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. Yamayoshi S, Koike S, J Virol 2011 85 4937 4946 10.1128/JVI.02358-10 21389126
40. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. Chen P, Song Z, Qi Y, Feng X, Xu N, Sun Y, Wu X, Yao X, Mao Q, Li X, Dong W, Wan X, Huang N, Shen X, Liang Z, Li W, J Biol Chem 2012 287 6406 6420 10.1074/jbc.M111.301622 22219187
41. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. Yamayoshi S, Iizuka S, Yamashita T, Minagawa H, Mizuta K, Okamoto M, Nishimura H, Sanjoh K, Katsushima N, Itagaki T, Nagai Y, Fujii K, Koike S, J Virol 2012 86 5686 5696 10.1128/JVI.00020-12 22438546
42. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL, Am J Pathol 2003 163 1379 1393 10.1016/S0002-9440(10)63496-7 14507646
43. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH, Lancet Infect Dis 2010 10 778 790 10.1016/S1473-3099(10)70194-8 20961813
44. Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. Nishimura Y, Wakita T, Shimizu H, PLoS Pathog 2010 6 1001174 10.1371/journal.ppat.1001174 21079683
45. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. Nishimura Y, Lee H, Hafenstein S, Kataoka C, Wakita T, Bergelson JM, Shimizu H, PLoS Pathog 2013 9 1003511 10.1371/journal.ppat.1003511 23935488
46. The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71. Hussain KM, Leong KL, Ng MM, Chu JJ, J Biol Chem 2011 286 309 321 10.1074/jbc.M110.168468 20956521
47. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. Yamayoshi S, Ohka S, Fujii K, Koike S, J Virol 2013 87 3335 3347 10.1128/JVI.02070-12 23302872
48. Cellular receptors for viruses: links to tropism and pathogenesis. Schneider-Schaulies J, J Gen Virol 2000 81 1413 1429 10811925
49. Cell-type-specific repression of internal ribosome entry site activity by double-stranded RNA-binding protein 76. Merrill MK, Dobrikova EY, Gromeier M, J Virol 2006 80 3147 3156 10.1128/JVI.80.7.3147-3156.2006 16537583
50. The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site. Merrill MK, Gromeier M, J Virol 2006 80 6936 6942 10.1128/JVI.00243-06 16809299
51. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. Ida-Hosonuma M, Iwasaki T, Yoshikawa T, Nagata N, Sato Y, Sata T, Yoneyama M, Fujita T, Taya C, Yonekawa H, Koike S, J Virol 2005 79 4460 4469 10.1128/JVI.79.7.4460-4469.2005 15767446
52. Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Wessely R, Klingel K, Knowlton KU, Kandolf R, Circulation 2001 103 756 761 10.1161/01.CIR.103.5.756 11156890
53. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. van den Broek MF, Muller U, Huang S, Aguet M, Zinkernagel RM, J Virol 1995 69 4792 4796 7609046
54. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. Khong WX, Yan B, Yeo H, Tan EL, Lee JJ, Ng JK, Chow VT, Alonso S, J Virol 2012 86 2121 2131 10.1128/JVI.06103-11 22130542
55. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. Kuo RL, Kao LT, Lin SJ, Wang RY, Shih SR, PLoS One 2013 8 63431 10.1371/journal.pone.0063431 23650567
56. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J, J Virol 2013 87 1690 1698 10.1128/JVI.01855-12 23175366
57. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. Lei X, Sun Z, Liu X, Jin Q, He B, Wang J, J Virol 2011 85 8811 8818 10.1128/JVI.00447-11 21697485
58. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. Lei X, Liu X, Ma Y, Sun Z, Yang Y, Jin Q, He B, Wang J, J Virol 2010 84 8051 8061 10.1128/JVI.02491-09 20519382
59. Enterovirus 71 blocks selectively type I interferon production through the 3C viral protein in mice. Lee YP, Wang YF, Wang JR, Huang SW, Yu CK, J Med Virol 2012 84 1779 1789 10.1002/jmv.23377 22997081
60. Engineering microRNA responsiveness to decrease virus pathogenicity. Kelly EJ, Hadac EM, Greiner S, Russell SJ, Nat Med 2008 14 1278 1283 10.1038/nm.1776 18953352
61. MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence. Tong L, Lin L, Wu S, Guo Z, Wang T, Qin Y, Wang R, Zhong X, Wu X, Wang Y, Luan T, Wang Q, Li Y, Chen X, Zhang F, Zhao W, Zhong Z, Nucleic Acids Res 2013 41 3760 3771 10.1093/nar/gkt058 23389951
62. MicroRNA-23b inhibits enterovirus 71 replication through downregulation of EV71 VPl protein. Wen BP, Dai HJ, Yang YH, Zhuang Y, Sheng R, Intervirology 2013 56 195 200 10.1159/000348504 23594713
63. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. Zheng Z, Ke X, Wang M, He S, Li Q, Zheng C, Zhang Z, Liu Y, Wang H, J Virol 2013 87 5645 5656 10.1128/JVI.02655-12 23468506
64. Roles of microRNAs in the life cycles of mammalian viruses. Gottwein E, Curr Top Microbiol Immunol 2013 371 201 227 23686237
65. Tissue-dependent paired expression of miRNAs. Ro S, Park C, Young D, Sanders KM, Yan W, Nucleic Acids Res 2007 35 5944 5953 10.1093/nar/gkm641 17726050
66. CVB infection and mechanisms of viral cardiomyopathy. Knowlton KU, Curr Top Microbiol Immunol 2008 323 315 335 18357777
67. MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region. Wang L, Qin Y, Tong L, Wu S, Wang Q, Jiao Q, Guo Z, Lin L, Wang R, Zhao W, Zhong Z, Antiviral Res 2012 93 270 279 10.1016/j.antiviral.2011. 12.004 22197249